Rapid sterility testing for cell and gene therapy products

In this presentation, Dr. Marta Veses Garcia, Symcel’s Head of Assay Development, gives an introduction to the calScreener+ system for fast microbial detection in cell and gene therapy products.

Powered by biocalorimetry, it delivers growth-based phenotypic sterility testing results in under three days, while minimizing risks of false results and enabling direct inoculation of complex cell therapy product matrices. For cell and gene therapy producers, this innovation can be a game-changer:

• Supports mitigation of contamination risks
• Addresses product matrix challenges
• Simplifies manufacturing processes
• Shortens time-to-market

The presentation covers an introduction to the technology, system validation, and specific data, including slow growers and inhibitory matrices.